Remdesivir is available through an FDA emergency use authorization. The FDA revoked the emergency use authorization for Chloroquine and Hydroxychloroquineare, except in the context of a clinical trial. Recommendations are against the use of lopinavir/ritonavir or other HIV protease inhibitors, unfavorable pharmacodynamics and clinical trials have not demonstrated a clinical benefit. There are insufficient data to recommend either for or against the use of convalescent plasma or immune globulins.
SNOMED_CT Problem=191415002 (PB0050); SNOMED_CT Cat-Tar=409022004 (CG0003, TG0073)